Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumor suppressor protein p53

  1. Lois Resnick-Silverman1,
  2. Selvon St. Clair1,
  3. Matthew Maurer1,
  4. Kathy Zhao1, and
  5. James J. Manfredi1,2,3
  1. 1Derald H. Ruttenberg Cancer Center and the 2Brookdale Center for Molecular and Developmental Biology, Mount Sinai School of Medicine, New York, New York 10029 USA

Abstract

There are two response elements for p53 in the promoter of the gene for the cyclin-dependent kinase inhibitor p21. The binding of p53 to the 5′ site was enhanced by incubation with monoclonal antibody 421, whereas the binding of p53 to the 3′ site was inhibited. Mutational analysis showed that a single-base change caused one element to behave like the other. A response element in the humancdc25C promoter is bound by p53 with properties similar to the 3′ site. These results identify two classes of p53-binding sites and suggest a mechanism for target gene selectivity by p53.

Keywords

Footnotes

  • 3 Corresponding author.

  • E-MAIL jmanfredi{at}smtplink.mssm.edu; FAX (212) 849-2446.

    • Received March 25, 1998.
    • Accepted May 27, 1998.
| Table of Contents

Life Science Alliance